Clinical Trial

Single-cell Sequencing of BLF to Guide the Treatment of Radiation Pneumonitis or Immune Checkpoint Inhibitor Pneumonitis

Recruiting Phase 1/2
View on ClinicalTrials.gov →
Record status
This record was last updated July 14, 2025 (before its estimated December 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
A multicenter, exploratory clinical research, to map the radiation or immune checkpoint inhibitor pneumonitis in patients with alveolar lavage single-celled map. Find out the pathogenesis and prevention strategies of radiation or immune checkpoint inhibitor pneumonitis. Specific treatment is given based on the recommendation of the treatment guidelines for radiation or immune checkpoint inhibitor pneumonitis and the results of single cell sequencing, which will become a new technology for clinical application.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2022-07-08; most recent amendment 2025-07-11.
Status change: Not Yet Recruiting → Recruiting 2023-02-12
Trial Details
NCT Number NCT05455034
Lead Sponsor Xinqiao Hospital of Chongqing
Conditions Pneumonitis
Enrollment 40 participants
Start Date 2023-08-01
Primary Completion 2025-12-30 (estimated)
Study Completion 2025-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-07-14